001044407 001__ 1044407
001044407 005__ 20260123203311.0
001044407 0247_ $$2doi$$a10.1038/s41598-025-06440-9
001044407 0247_ $$2datacite_doi$$a10.34734/FZJ-2025-03170
001044407 037__ $$aFZJ-2025-03170
001044407 082__ $$a600
001044407 1001_ $$0P:(DE-HGF)0$$aSchaffrath, Kim$$b0$$eCorresponding author
001044407 245__ $$aEffects of taurine, brimonidine and betaxolol on oscillation modulation and stimulation efficiency in degenerated rd10 mouse retinas
001044407 260__ $$a[London]$$bSpringer Nature$$c2025
001044407 3367_ $$2DRIVER$$aarticle
001044407 3367_ $$2DataCite$$aOutput Types/Journal article
001044407 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1769162720_14858
001044407 3367_ $$2BibTeX$$aARTICLE
001044407 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001044407 3367_ $$00$$2EndNote$$aJournal Article
001044407 500__ $$aThe authors thank the Institute of Laboratory Animal Science (Faculty of Medicine, RWTH Aachen University) for support, Anne Rohn (Department of Ophthalmology, University Hospital RWTH Aachen) for excellent technical assistance, and Sabine Diarra for her efforts to prepare the grant application for the Pro Retina Foundation.Open Access funding enabled and organized by Projekt DEAL.
001044407 520__ $$aThe rd10 mouse is a widely used model for degenerative retinal diseases such as retinitis pigmentosa(RP). Its retina shows rhythmic spontaneous activity at a frequency of three to seven Hz, andthe retinal ganglion cells (RGCs) are less electrically excitable. We hypothesize that the electricalexcitability can be improved by suppressing the oscillations using the neuroprotective drugs2-aminoethanesulphonic acid (taurine), brimonidine and betaxolol. These are involved in calciumhomeostasis and may play a crucial role in neuroprotection and excitotoxicity by preventing Ca2+overload. Spontaneous activity and responses to electrical stimulation of isolated retinas from3- to 4-month-old rd10 mice were recorded using multielectrode arrays. At defined times, theneuroprotectants were repeatedly added to the medium according to a standardized protocol toanalyze the reproducibility and reversibility of their effects. Taurine and betaxolol significantly reducedoscillations and bursting behavior and ameliorated electrical efficiency. Brimonidine only reduced thefrequency of oscillations. The effects on oscillation, spontaneous firing frequency, bursting behaviorand stimulation efficiency were reproducible and reversible. The drugs tested appear to be promisingtherapeutic candidates for improving the residual function of RGCs. They will be further investigatedand combined with other RP treatments, such as retinal prostheses, in the future.
001044407 536__ $$0G:(DE-HGF)POF4-5244$$a5244 - Information Processing in Neuronal Networks (POF4-524)$$cPOF4-524$$fPOF IV$$x0
001044407 536__ $$0G:(GEPRIS)424556709$$aGRK 2610 - GRK 2610: Innovative Schnittstellen zur Retina für optimiertes künstliches Sehen - InnoRetVision (424556709)$$c424556709$$x1
001044407 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001044407 7001_ $$0P:(DE-HGF)0$$aIngensiep, Claudia$$b1
001044407 7001_ $$0P:(DE-Juel1)131939$$aMüller, Frank$$b2$$ufzj
001044407 7001_ $$0P:(DE-Juel1)209653$$aWalter, Peter$$b3$$ufzj
001044407 7001_ $$0P:(DE-HGF)0$$aJohnen, Sandra$$b4
001044407 773__ $$0PERI:(DE-600)2615211-3$$a10.1038/s41598-025-06440-9$$gVol. 15, no. 1, p. 20209$$n1$$p20209$$tScientific reports$$v15$$x2045-2322$$y2025
001044407 8564_ $$uhttps://juser.fz-juelich.de/record/1044407/files/Scientific_Reports_M%C3%BCller_06_2025.pdf$$yOpenAccess
001044407 909CO $$ooai:juser.fz-juelich.de:1044407$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
001044407 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131939$$aForschungszentrum Jülich$$b2$$kFZJ
001044407 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)209653$$aForschungszentrum Jülich$$b3$$kFZJ
001044407 9131_ $$0G:(DE-HGF)POF4-524$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5244$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vMolecular and Cellular Information Processing$$x0
001044407 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)1040$$2StatID$$aDBCoverage$$bZoological Record$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bSCI REP-UK : 2022$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-07-29T15:28:26Z
001044407 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-07-29T15:28:26Z
001044407 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001044407 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)1150$$2StatID$$aDBCoverage$$bCurrent Contents - Physical, Chemical and Earth Sciences$$d2024-12-18
001044407 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-18
001044407 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001044407 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-18
001044407 920__ $$lyes
001044407 9201_ $$0I:(DE-Juel1)IBI-1-20200312$$kIBI-1$$lMolekular- und Zellphysiologie$$x0
001044407 9201_ $$0I:(DE-Juel1)INW-1-20231219$$kINW-1$$lKatalytische Grenzflächen$$x1
001044407 980__ $$ajournal
001044407 980__ $$aVDB
001044407 980__ $$aUNRESTRICTED
001044407 980__ $$aI:(DE-Juel1)IBI-1-20200312
001044407 980__ $$aI:(DE-Juel1)INW-1-20231219
001044407 9801_ $$aFullTexts